Literature DB >> 15572687

c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.

Jing Liu1, Yuzuru Minemoto, Anning Lin.   

Abstract

Two ubiquitously expressed isoforms of c-Jun N-terminal protein kinase (JNK), JNK1 and JNK2, have shared functions and different functions. However, the molecular mechanism is unknown. Here we report that JNK1, but not JNK2, is essential for tumor necrosis factor alpha (TNF-alpha)-induced c-Jun kinase activation, c-Jun expression, and apoptosis. Using mouse fibroblasts deficient in either Jnk1 or Jnk2, we found that JNK1 was activated by TNF-alpha, whereas JNK2 activation was negligible. In addition, JNK2 interfered with JNK1 activation via its "futile" phosphorylation by upstream kinases. Consequently, expression and activation of c-Jun, which depends on JNK activity, were impaired in Jnk1 null cells but enhanced in Jnk2 null cells. TNF-alpha-induced apoptosis was also suppressed in Jnk1 null fibroblasts but increased in Jnk2 null cells. Thus, our results provide a molecular mechanism underlying the different biological functions of JNK isoforms.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15572687      PMCID: PMC533995          DOI: 10.1128/MCB.24.24.10844-10856.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  31 in total

Review 1.  Mammalian MAP kinase signalling cascades.

Authors:  L Chang; M Karin
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

Review 2.  Signal transduction by the JNK group of MAP kinases.

Authors:  R J Davis
Journal:  Cell       Date:  2000-10-13       Impact factor: 41.582

3.  Inhibition of JNK activation through NF-kappaB target genes.

Authors:  G Tang; Y Minemoto; B Dibling; N H Purcell; Z Li; M Karin; A Lin
Journal:  Nature       Date:  2001-11-15       Impact factor: 49.962

4.  The JNKK2-JNK1 fusion protein acts as a constitutively active c-Jun kinase that stimulates c-Jun transcription activity.

Authors:  C Zheng; J Xiang; T Hunter; A Lin
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

Review 5.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

6.  Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2.

Authors:  K Sabapathy; W Jochum; K Hochedlinger; L Chang; M Karin; E F Wagner
Journal:  Mech Dev       Date:  1999-12       Impact factor: 1.882

7.  Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway.

Authors:  C Tournier; P Hess; D D Yang; J Xu; T K Turner; A Nimnual; D Bar-Sagi; S N Jones; R A Flavell; R J Davis
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

8.  The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development.

Authors:  C Y Kuan; D D Yang; D R Samanta Roy; R J Davis; P Rakic; R A Flavell
Journal:  Neuron       Date:  1999-04       Impact factor: 17.173

9.  Identification of a dual specificity kinase that activates the Jun kinases and p38-Mpk2.

Authors:  A Lin; A Minden; H Martinetto; F X Claret; C Lange-Carter; F Mercurio; G L Johnson; M Karin
Journal:  Science       Date:  1995-04-14       Impact factor: 47.728

10.  c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms.

Authors:  R Wisdom; R S Johnson; C Moore
Journal:  EMBO J       Date:  1999-01-04       Impact factor: 11.598

View more
  89 in total

1.  E3 ubiquitin ligase Mule ubiquitinates Miz1 and is required for TNFalpha-induced JNK activation.

Authors:  Yi Yang; HanhChi Do; Xuejun Tian; Chaozheng Zhang; Xinyuan Liu; Laura A Dada; Jacob I Sznajder; Jing Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-12       Impact factor: 11.205

2.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

3.  Phosphorylation of Bcl-associated death protein (Bad) by erythropoietin-activated c-Jun N-terminal protein kinase 1 contributes to survival of erythropoietin-dependent cells.

Authors:  Hongbin Deng; Jingpu Zhang; Taewon Yoon; Danqing Song; Diandong Li; Anning Lin
Journal:  Int J Biochem Cell Biol       Date:  2010-11-21       Impact factor: 5.085

4.  C-Jun N-terminal kinase 2 promotes graft injury via the mitochondrial permeability transition after mouse liver transplantation.

Authors:  T P Theruvath; C Czerny; V K Ramshesh; Z Zhong; K D Chavin; J J Lemasters
Journal:  Am J Transplant       Date:  2008-07-28       Impact factor: 8.086

5.  The c-Jun NH2-terminal kinase 2 plays a dominant role in human epidermal neoplasia.

Authors:  Hengning Ke; Rebecca Harris; Jonathan L Coloff; Jane Y Jin; Benjamin Leshin; Paula Miliani de Marval; Shiying Tao; Jeffrey C Rathmell; Russell P Hall; Jennifer Y Zhang
Journal:  Cancer Res       Date:  2010-03-30       Impact factor: 12.701

6.  TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.

Authors:  Shuping Zhong; Jody Fromm; Deborah L Johnson
Journal:  Mol Cell Biol       Date:  2006-10-30       Impact factor: 4.272

7.  c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets.

Authors:  J L Varona-Santos; A Pileggi; R D Molano; N Y Sanabria; A Ijaz; M Atsushi; H Ichii; R L Pastori; L Inverardi; C Ricordi; A Fornoni
Journal:  Diabetologia       Date:  2008-10-14       Impact factor: 10.122

8.  c-Jun N-terminal kinase promotes stem cell phenotype in triple-negative breast cancer through upregulation of Notch1 via activation of c-Jun.

Authors:  X Xie; T S Kaoud; R Edupuganti; T Zhang; T Kogawa; Y Zhao; G B Chauhan; D N Giannoukos; Y Qi; D Tripathy; J Wang; N S Gray; K N Dalby; C Bartholomeusz; N T Ueno
Journal:  Oncogene       Date:  2016-12-12       Impact factor: 9.867

9.  CHOP overexpression sensitizes human non-small cell lung cancer cells to cisplatin treatment by Bcl-2/JNK pathway.

Authors:  Li-Le Wang; Rui-Cheng Hu; Ai-Guo Dai; Shuang-Xiang Tan; Ming Xu; Chun-Chu Kong; Yun-Rong Chen; Dai-Yan Fu
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  Effects of hepatocyte growth factor on glutathione synthesis, growth, and apoptosis is cell density-dependent.

Authors:  Heping Yang; Nathaniel Magilnick; Meng Xia; Shelly C Lu
Journal:  Exp Cell Res       Date:  2007-09-29       Impact factor: 3.905

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.